PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pneumology and Critical Care Medicine, University of Heidelberg, Heidelberg, Germany.\', \'Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO, USA.\', \'Institute of Applied Health Research, University of Birmingham, Birmingham, England.\', \'Pulmonology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.\', \'Department of Pulmonary and Infectious Diseases, Hannover Medical School, Hannover, Germany.\', \'Department of Internal Medicine and Pneumology, University Hospital Marburg, Marburg, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2147/COPD.S325211
?:doi
?:hasPublicationType
?:journal
  • International journal of chronic obstructive pulmonary disease
is ?:pmid of
?:pmid
?:pmid
  • 34754184
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all